Literature DB >> 18483141

Iodinated contrast media and their adverse reactions.

Jagdish Singh1, Aditya Daftary.   

Abstract

Cross-use of technology between nuclear medicine and radiology technologists is expanding. The growth of PET/CT and the increasing use of intravenous contrast agents during these procedures bring the nuclear medicine technologist into direct contact with these agents and their associated complications. A basic understanding of the occurrence, risk factors, clinical features, and management of these procedures is of increasing importance to the nuclear medicine technologist. After reading this article, the technologist will be able to list the factors that increase the risk of contrast reactions; understand ways to minimize the occurrence of contrast reactions; and develop a plan to identify, treat, and manage the reactions effectively.

Mesh:

Substances:

Year:  2008        PMID: 18483141     DOI: 10.2967/jnmt.107.047621

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  48 in total

Review 1.  Adverse reactions to iodinated contrast media.

Authors:  Wendy Bottinor; Pritam Polkampally; Ion Jovin
Journal:  Int J Angiol       Date:  2013-09

2.  Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.

Authors:  X Li; J Chen; L Zhang; H Liu; S Wang; X Chen; J Fang; S Wang; W Zhang
Journal:  Br J Radiol       Date:  2015-01-13       Impact factor: 3.039

Review 3.  Practical instructions for using drugs in CT and MR cardiac imaging.

Authors:  Giuseppe Rovere; Agostino Meduri; Giancarlo Savino; Francesco Ciriaco Flammia; Francesca Lo Piccolo; Maria Rachele Pia Carafa; Anna Rita Larici; Luigi Natale; Biagio Merlino; Riccardo Marano
Journal:  Radiol Med       Date:  2020-08-24       Impact factor: 3.469

4.  Multifunctional in vivo vascular imaging using near-infrared II fluorescence.

Authors:  Guosong Hong; Jerry C Lee; Joshua T Robinson; Uwe Raaz; Liming Xie; Ngan F Huang; John P Cooke; Hongjie Dai
Journal:  Nat Med       Date:  2012-11-18       Impact factor: 53.440

5.  Fusion imaging: a novel staging modality in testis cancer.

Authors:  Joseph R Sterbis; Kevin R Rice; Marcia C Javitt; Noah S Schenkman; Stephen A Brassell
Journal:  J Cancer       Date:  2010-11-05       Impact factor: 4.207

6.  Synthesis, Characterization, In Vitro Phantom Imaging, and Cytotoxicity of A Novel Graphene-Based Multimodal Magnetic Resonance Imaging - X-Ray Computed Tomography Contrast Agent.

Authors:  Gaurav Lalwani; Joe Livingston Sundararaj; Kenneth Schaefer; Terry Button; Balaji Sitharaman
Journal:  J Mater Chem B       Date:  2014-06-14       Impact factor: 6.331

Review 7.  Imaging of acute pulmonary embolism.

Authors:  Maria Komissarova; Suzanne Chong; Kirk Frey; Baskaran Sundaram
Journal:  Emerg Radiol       Date:  2012-11-14

Review 8.  Advances in functional X-ray imaging techniques and contrast agents.

Authors:  Hongyu Chen; Melissa M Rogalski; Jeffrey N Anker
Journal:  Phys Chem Chem Phys       Date:  2012-10-21       Impact factor: 3.676

Review 9.  Iobitridol: a review of its use as a contrast medium in diagnostic imaging.

Authors:  Paul L McCormack
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

10.  Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.

Authors:  Vivekanandan Kalaiselvan; Surbhi Sharma; Gyanendra Nath Singh
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.